Motivations for participating in an HIV vaccine efficacy trial.
about
Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approachesEffect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical preventionExperiences in recruiting volunteers through community based initiatives in phase-1 vaccine trials in IndiaEnhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials.HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco.Enhancing HIV vaccine trial consent preparedness among street drug usersIn "Step" with HIV Vaccines? A Content Analysis of Local Recruitment Campaigns for an International HIV Vaccine StudyPromoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement?Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania.Pregnancy in HIV clinical trials in Sub Saharan Africa: failure of consent or contraception?A cluster randomized controlled trial of an adolescent HIV prevention program among Bahamian youth: effect at 12 months post-intervention.So different, yet so similar: meta-analysis and policy modeling of willingness to participate in clinical trials among Brazilians and IndiansEvaluation of an intervention among adolescents to reduce preventive misconception in HIV vaccine clinical trials.Theoretical model of critical issues in informed consent in HIV vaccine trialsTime will tell: community acceptability of HIV vaccine research before and after the "Step Study" vaccine discontinuationLessons drawn from recent HIV vaccine efficacy trials.Selectively willing and conditionally able: HIV vaccine trial participation among women at "high risk" of HIV infection.Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: a survey conducted among adolescents in Soweto, South Africa.Conceptual framework for behavioral and social science in HIV vaccine clinical research.Beliefs About Anal Cancer among HIV-Infected Women: Barriers and Motivators to Participation in Research.Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in UgandaMotivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, TanzaniaRetention of clinical trial participants in a study of nongonococcal urethritis (NGU), a sexually transmitted infection in men.Motivations for participating in a clinical trial on an avian influenza vaccineWillingness to participate in future HIV prevention studies among gay and bisexual men in Scotland, UK: a challenge for intervention trials.'It's not about money, it's about my health': determinants of participation and adherence among women in an HIV-HSV2 prevention trial in Johannesburg, South AfricaRecruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trialsCo-enrollment in multiple HIV prevention trials - experiences from the CAPRISA 004 Tenofovir gel trial.Anticipated changes in sexual risk behaviour following vaccination with a low-efficacy HIV vaccine: survey results from a South African township.Patients' motivations for participating in cardiovascular clinical trials: a local perspectiveMaternal participant experience in a South African birth cohort study enrolling healthy pregnant women and their infants.Men who have sex with men in Kisumu, Kenya: comfort in accessing health services and willingness to participate in HIV prevention studiesThe Motivations and Experiences of Young Women in a Microbicide Trial in the USA and Puerto Rico.Parental regret regarding children's vaccines-The correlation between anticipated regret, altruism, coping strategies and attitudes toward vaccines.Representation of Latinos and Blacks in screening for and enrollment into preventive HIV vaccine trials in New York City.Willingness to volunteer in a Phase I/II HIV vaccine trial: a study among police officers in Dar es Salaam, Tanzania.Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES).Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study.Participants' responsibilities in clinical research.Motivators to participation in medical trials: the application of social and personal categorization.
P2860
Q27005602-10984CC9-5E17-48C1-A404-4F9227568854Q30206105-28E730D2-5BE3-4974-A4DB-600161970150Q30219959-DFDC8D9F-4FB5-4FFD-A6E1-1106F573368EQ30223510-AC1A95F8-591C-4DFD-890D-941F7EE3CA4CQ30226766-AEE819F6-28BF-416E-A683-0F791933B3D1Q30227101-EB64B5B5-760D-4611-BBBA-70B0762B5FAFQ30378981-020276C7-F90B-44FD-8DD6-E1C2D87E10DAQ30392323-FCA4B4C8-8E01-46CB-A830-EA4053662193Q30983687-5068BB32-DB96-441A-A5AE-F559EA2F7789Q31139344-E0740FCF-DC55-4531-B98E-5805C6AE4B31Q33631911-ABD1E405-C2EA-4169-8415-F863ED1D1186Q33778700-9DA7DE18-94A7-4ED1-BA02-0AB5EC381357Q33940778-5C13E7C7-FE8F-4C61-881E-ECE8FDA730CEQ34005683-8EA1BB05-223D-4114-8A60-EBB0F79429CDQ34376994-70DB15DA-F3F6-486D-B1D2-C33CD9138C76Q34816639-DD4B9946-D666-438B-9B04-CB7D93B885E1Q35187935-2F179CC4-BB3E-4917-AAE6-918FD87EC93BQ35219089-27E43F96-DB1D-43CB-A192-46E406F4FE5AQ35301155-EB8390E0-492A-40A5-9F81-2CFC2916C791Q35740381-014055E3-C442-4BC4-A512-0B96B2090B99Q35863340-C774A9AE-4C35-4F61-89EB-52DE8624CBF9Q35934431-8AC0D4B7-FCFE-4A74-B9C8-C82D7A3E9300Q35942053-B2DF174D-7658-42C3-916E-A7F83B21901CQ35945862-75614891-8459-4899-B832-CAD581654A38Q36106497-C7A97528-9905-40B9-8125-1D0DB1A0BD4AQ36194047-0F0238CB-0024-4560-A823-803FC89FCBC0Q36582002-324C8697-90D4-4A7E-B90D-2274BA49728AQ36739446-E193C691-330A-469B-8F90-3BCB29B825CBQ36975561-3ED6E42E-163F-42A7-85DE-25531C417C46Q37041362-882C4085-0572-40FE-83AF-FAE67A7D2CC5Q37111317-9E53DBCF-B820-42DC-BA99-C6E831C7FD43Q37220112-27706B86-E5ED-46C0-9440-184C0A69C68CQ37373898-DACD247D-A912-4313-8F8B-BF4CCA2798FFQ37400915-BC773497-B40A-475A-B644-259BCF642C34Q37409508-E446DA8D-B680-4E04-9537-B40D93A0F83CQ37427237-396EE83C-78F4-4640-BFF6-25032276E838Q37485276-E11C1EDF-E860-4C0E-904A-F96D1C1D910EQ37503472-45E049A1-30D6-4C1D-BBB2-212E4EEAA401Q37654584-8D5FF1FD-4C9B-4100-99FD-80AAEF580A2CQ38077582-07C8BFFD-871F-4948-91B0-F34595BF728C
P2860
Motivations for participating in an HIV vaccine efficacy trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Motivations for participating in an HIV vaccine efficacy trial.
@en
Motivations for participating in an HIV vaccine efficacy trial.
@nl
type
label
Motivations for participating in an HIV vaccine efficacy trial.
@en
Motivations for participating in an HIV vaccine efficacy trial.
@nl
prefLabel
Motivations for participating in an HIV vaccine efficacy trial.
@en
Motivations for participating in an HIV vaccine efficacy trial.
@nl
P2093
P50
P1476
Motivations for participating in an HIV vaccine efficacy trial.
@en
P2093
Brad Bartholow
David McKirnan
Goli Vamshidar
Grant Colfax
Judith Neidig
Marc Gurwith
P304
P356
10.1097/01.QAI.0000152039.88422.EC
P407
P577
2005-07-01T00:00:00Z